Paper2803071
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.
Krupp LB and 3 others. Arch Neurol, 1989. Cited by 4,925 papers, by iCite.
Cite this record
ConductScience Library. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Papers, record 2803071. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2803071
- Disease
- primary biliary cholangitis51 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fatigue | Major topic |
| Lupus Erythematosus, Systemic | Major topic |
| Multiple Sclerosis | Major topic |
| Severity of Illness Index | Major topic |
| Adult | |
| Disability Evaluation | |
| Humans | |
| Neurologic Examination |
Source PubMed
Trials44
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00689793 | Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors | Background | ClinicalTrials.gov | |
| NCT01785485 | IMPACT - Integrative Medicine PrimAry Care Trial | Background | ClinicalTrials.gov | |
| NCT02281513 | Activity and Nutrition Trial in Lupus to Energize and Renew | Background | ClinicalTrials.gov | |
| NCT02653287 | Lupus Intervention for Fatigue Trial | Background | ClinicalTrials.gov | |
| NCT02937012 | Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders | Results | ClinicalTrials.gov | |
| NCT03070730 | Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist | Background | ClinicalTrials.gov | |
| NCT03446807 | Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism | Background | ClinicalTrials.gov | |
| NCT03621761 | Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue | Background | ClinicalTrials.gov | |
| NCT03825770 | Pilot Study of an Educational Program for Adults on Hemodialysis With Fatigue | Background | ClinicalTrials.gov | |
| NCT04137809 | TREAT Foot Drop After Stroke With Ankle Robot | Background | ClinicalTrials.gov | |
| NCT04267107 | Managing Fatigue in People With Parkinson's Disease | Background | ClinicalTrials.gov | |
| NCT04592354 | Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors | Background | ClinicalTrials.gov | |
| NCT04660227 | Exercise Training in Pediatric-Onset Multiple Sclerosis Patients | Background | ClinicalTrials.gov | |
| NCT04673045 | Effects of Neuromuscular Electrical Stimulation on Individuals With Chronic Stroke in Patients With Chronic Stroke | Background | ClinicalTrials.gov | |
| NCT04733456 | Brain Activity and Oxygenation Inflammatory Bowel Disease (IBD) Patients | Background | ClinicalTrials.gov | |
| NCT04780828 | Investigation of the Effects of Different Levels of Obesity on the Respiratory System | Background | ClinicalTrials.gov | |
| NCT04827550 | Fatigue Levels in Fibromyalgia Syndrome | Background | ClinicalTrials.gov | |
| NCT04895371 | Tele-Physiotherapy After COVID-19 Hospitalization | Background | ClinicalTrials.gov | |
| NCT05012826 | Osteopathy and Physiotherapy Compared to Physiotherapy Alone on Fatigue and Functional Status in Long COVID | Background | ClinicalTrials.gov | |
| NCT05319093 | Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients | Background | ClinicalTrials.gov |
Cited by2,437
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4,925 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42971600 | Pulmonary function, functional capacity and physical activity in patients with SLE: a cross-sectional study. | Lupus Sci Med | 2026 | https://conductscience.org/library/papers/42971600 | PubMed |
| 42968108 | STABILOOP, a cohort trial to assess automated insulin delivery in the management of patients living with type 1 diabetes who are eligible for islet transplantation. | Trials | 2026 | https://conductscience.org/library/papers/42968108 | PubMed |
| 42959851 | Rationale and design of RECOVER - a prospective, longitudinal cardiac rehabilitation registry. | Am Heart J Plus | 2026 | https://conductscience.org/library/papers/42959851 | PubMed |
| 42955555 | Concepts and Assessment of Fatigue in Myasthenia Gravis: A Scoping Review. | Neurol Ther | 2026 | https://conductscience.org/library/papers/42955555 | PubMed |
| 42953804 | Symptoms as Correlates of Health-Related Quality of Life in Black and White Individuals With Multiple Sclerosis. | Int J MS Care | 2026 | https://conductscience.org/library/papers/42953804 | PubMed |
| 42953443 | Feasibility, Acceptability, and Initial Efficacy of a Wheelchair Exercise Training Program in People With Multiple Sclerosis. | Int J MS Care | 2026 | https://conductscience.org/library/papers/42953443 | PubMed |
| 42952477 | Effect of mindfulness breathing versus acupoint stimulation on anxiety, fatigue, and sleep quality among children undergoing stem cell transplantation: a three-arm randomized controlled trial. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42952477 | PubMed |
| 42945894 | Associations between salivary HHV-6 and long COVID severity in a cross-sectional, case-control analysis. | EBioMedicine | 2026 | https://conductscience.org/library/papers/42945894 | PubMed |
| 42942946 | Effects of Oral L-Arginine on Everyday Persistent Fatigue, Sleep, and Post-Exercise Lactate Recovery in Community-Dwelling Working-Age Adults: A Double-Blind, Placebo-Controlled Randomized Trial. | Nutrients | 2026 | https://conductscience.org/library/papers/42942946 | PubMed |
| 42940582 | Problematic Social Media Use and Insomnia Severity Among Saudi University Students: Cross-Sectional Indirect-Association Analyses Involving Fatigue and Anxiety. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42940582 | PubMed |
| 42931152 | Subjective Sleep Quality in Relation to Relapse Status in Relapsing-Remitting Multiple Sclerosis: A Propensity Score-Matched Nested Case-Control Analysis. | Neurol Int | 2026 | https://conductscience.org/library/papers/42931152 | PubMed |
| 42929191 | Continuous Subcutaneous Foslevodopa/Foscarbidopa Improves Nonmotor Symptoms and Fluctuations in Parkinson's Disease. | Eur J Neurol | 2026 | https://conductscience.org/library/papers/42929191 | PubMed |
| 42924310 | Fatigue, anthropometric profile, and health-related quality of life among fifth-year medical students: A single-center cross-sectional study from Kazakhstan. | J Educ Health Promot | 2026 | https://conductscience.org/library/papers/42924310 | PubMed |
| 42921597 | "There's No Magic Pill": A Multimethods Qualitative Study Exploring Routine Fatigue Care in People With Multiple Sclerosis. | Int J MS Care | 2025 | https://conductscience.org/library/papers/42921597 | PubMed |
| 42918252 | Physical and psychological burden in RRMS: depression and fatigue beyond disease duration. | Arq Neuropsiquiatr | 2026 | https://conductscience.org/library/papers/42918252 | PubMed |
| 42906448 | Morning lighting intervention reduces fatigue and improves sleep in Parkinson disease. | Neurotherapeutics | 2026 | https://conductscience.org/library/papers/42906448 | PubMed |
| 42903451 | Intra-operative oxygen concentration could affect postoperative morbidity-results of a randomised controlled feasibility trial (PULSE Ox). | Anaesth Rep | 2026 | https://conductscience.org/library/papers/42903451 | PubMed |
| 42903028 | Feasibility of Aerobic Exercise in People With Advanced Multiple Sclerosis: Characterizing Acute Responses to Inform Exercise Prescription. | Int J MS Care | 2025 | https://conductscience.org/library/papers/42903028 | PubMed |
| 42903011 | Ocrelizumab Wearing-Off Phenomenon: Prevalence, Predictors, and Outcomes After Intervention. | Int J MS Care | 2025 | https://conductscience.org/library/papers/42903011 | PubMed |
| 42898520 | Latent classes and symptom network analysis of kinesiophobia in older adult patients with chronic obstructive pulmonary disease. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42898520 | PubMed |
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| URSODIOL | CHEMBL1551 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1551 | ChEMBL |
| BEZAFIBRATE | CHEMBL264374 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL264374 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2803071
GET https://conductscience.org/api/papers/v1/2803071/trials?page=2